cannavalon

PRESS RELEASE – May 10, 2018 9:00 AM/PM EASTERN Cannavalon Biosciences, Inc.  “Affinity Bio Partners and HCXP selected for Cannavalon Biosciences Proof of Concept Epilepsy Clinical Study” LOCATION Santa Rosa, California. –(BUSINESS WIRE)— Cannavalon Biosciences, Inc. announced today that it has selected Affinity Bio Partners, LLC as their Clinical Research Organization and their technology partner,…

clinicaltrial1

To view original Press Release on BioSpace click here. Published: Dec 19, 2017 HARRISBURG, Pennsylvania and PHOENIXVILLE, Pennsylvania.–(BUSINESS WIRE)—Affinity Bio Partners Affinity BioCeuticals and HCXperience (HCXP) announced that they are technology partners. HCXP is leading the way in improving the client experience through electronic real-time software development. HCXP (supports, monitors, maintains) clients and partners nationwide…

© HCXP Inc 2017 All Rights Reserved.